Floatz logo

Therapeutic Asset Ratings

9,922 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Niraparib
Rectal Neoplasm
University of IowaP1CC (43)
Nivestim
Plasmablastic Lymphoma
City of Hope Medical CenterP1CC (43)
Nivestim
Metastatic Carcinoma In The Bone
Albert Einstein College of MedicineP1CC (43)
Nivolumab
Medullary Thyroid Gland Carcinoma
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Autoimmune Disease
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Breast Adenocarcinoma
Mayo ClinicP1CC (43)
Nivolumab
Primary Melanoma Of The Central Nervous System
M.D. Anderson Cancer CenterP1CC (43)
Nivolumab
Crohn Disease
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Dermatomyositis
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Anaplastic Astrocytoma
University of FloridaP1CC (43)
Nivolumab
Grade III Glioma
Sabine Mueller, MD, PhDP1CC (43)
Nivolumab
Histiocytic And Dendritic Cell Neoplasm
Mayo ClinicP1CC (43)
Nivolumab
Inflammatory Bowel Disease
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Invasive Breast Carcinoma
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Malignant Leptomeningeal Tumor
M.D. Anderson Cancer CenterP1CC (43)
Nivolumab
Meningeal Melanocytoma
M.D. Anderson Cancer CenterP1CC (43)
Nivolumab
Malignant Conjunctival Melanoma
Fred Hutchinson Cancer CenterP1CC (43)
Nivolumab
Oligoastrocytoma
University of FloridaP1CC (43)
Nivolumab
Psoriasis
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Psoriatic Arthritis
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Mixed Phenotype Acute Leukemia
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Rheumatoid Arthritis
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Sjogren Syndrome
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Mycosis Fungoides And Variants
National Cancer Institute (NCI)P1CC (43)
Nivolumab
Systemic Lupus Erythematosus
National Cancer Institute (NCI)P1CC (43)
Showing 2926 to 2950 of 9,922 assets
PreviousPage 118 of 397Next